Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
CRTO Criteo SA
ATEX Anterix Inc
ALKT Alkami Technology Inc
PSX Phillips 66
PSA Public Storage
PRU Prudential Financial Inc
PPL PPL Corp
PNC PNC Financial Services Group Inc
PM Philip Morris International Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.

Price
Delayed
$115.08
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
115.56
Day's Low
114.45
Volume
(Light)

Today's volume of 1,870,528 shares is on pace to be much lighter than ABBV's 10-day average volume of 5,722,228 shares.

1,870,528

Display:

Providers:

UpdateCancel
6 providers
Yesterday's News, August 04, 2021
August 02, 2021
August 01, 2021
July 30, 2021
July 29, 2021
July 27, 2021
July 25, 2021
July 23, 2021
July 21, 2021
July 20, 2021
July 16, 2021
July 15, 2021
July 14, 2021
July 09, 2021
July 08, 2021
July 07, 2021
July 02, 2021
Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.